We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sinclair Pha | LSE:SPH | London | Ordinary Share | GB0033856740 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 31.80 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSPH
RNS Number : 8839M
Sinclair Pharma PLC
18 October 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or Sinclair Pharma Plc the underlying issuer Sedol 3385674 of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------- -------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): --------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights ------------------------------------------------------------ ------------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------ ------------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------ ------------------------------------- An event changing the breakdown of voting rights X ------------------------------------------------------------ ------------------------------------- Other (please specify): ---------------------------------------------------------- ------------------------------------- 3. Full name of person(s) (1) Lansdowne Partners International subject to the Limited notification obligation: (2) Lansdowne Partners Limited (iii) (3) Lansdowne Partners (UK) LLP ----------------------------------------------------------- -------------------------------------- 4. Full name of shareholder(s) HSBC Client Holdings Nominee (if different from 3.):(iv) (UK) Ltd (Registered Shareholder) ----------------------------------------------------------- -------------------------------------- 5. Date of the transaction 30/09/2016 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- -------------------------------------- 6. Date on which issuer 18/10/2016 notified: ----------------------------------------------------------- -------------------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 12% ----------------------------------------------------------- -------------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- ----------------------------------- ------------------------------------------------------------------ Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- ---------------- ----------------- -------------- ----------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ------------ ------------- -------------- --------- ------------ ------------ ----------- Ordinary Shares 59,987,523 59,987,523 59,987,523 11.95% ---------------- ----------------- -------------- --------- ------------ ------------ ----------- GB0033856740 ------------- ------------ ------------- ------------ ------- ------------ -------- --------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- -------------- --------------------------------- ------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- -------------- --------------- ---------------- ------------------------- ----------------------- Nominal Delta --------------- -------------- --------------- ---------------- ------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ---------------------------------------------------- ---------------------------------------------------------------- 59,987,523 11.95% ---------------------------------------------------- ---------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ---------------------------------------------------------------------------------------------- Lansdowne Partners International Limited is the parent undertaking of Lansdowne Partners Limited which is the First Corporate Member of Lansdowne Partners (UK) LLP Proxy Voting: ---------------------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ------------------------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ------------------------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ------------------------------- 13. Additional information: Based on total voting rights of 502,089,508 ------------------------------------------------------------- ------------------------------- 14. Contact name: Ruari Paton ------------------------------------------------------------- ------------------------------- 15. Contact telephone number: +44 020 7290 5500 ------------------------------------------------------------- -------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLMPBFTMBIBBRF
(END) Dow Jones Newswires
October 18, 2016 12:55 ET (16:55 GMT)
1 Year Sinclair Pharma Chart |
1 Month Sinclair Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions